Psoriasis and Cardiovascular Risk—Do Promising New Biomarkers Have Clinical Impact?

S Kaur, K Kingo, M Zilmer - Mediators of inflammation, 2017 - Wiley Online Library
Epidemiological studies suggest an increased prevalence of cardiovascular disease (CVD)
in patients with psoriasis (PS). Therefore, emphasis has lately been laid on the necessity for …

Psoriasis and Cardiovascular Risk-Do Promising New Biomarkers Have Clinical Impact?

S Kaur, K Kingo, M Zilmer - Mediators of Inflammation, 2017 - europepmc.org
Epidemiological studies suggest an increased prevalence of cardiovascular disease (CVD)
in patients with psoriasis (PS). Therefore, emphasis has lately been laid on the necessity for …

[HTML][HTML] Psoriasis and Cardiovascular Risk—Do Promising New Biomarkers Have Clinical Impact?

S Kaur, K Kingo, M Zilmer - Mediators of Inflammation, 2017 - ncbi.nlm.nih.gov
Epidemiological studies suggest an increased prevalence of cardiovascular disease (CVD)
in patients with psoriasis (PS). Therefore, emphasis has lately been laid on the necessity for …

[PDF][PDF] Psoriasis and Cardiovascular Risk—Do Promising New Biomarkers Have Clinical Impact?

S Kaur, K Kingo, M Zilmer - 2017 - core.ac.uk
Epidemiological studies suggest an increased prevalence of cardiovascular disease (CVD)
in patients with psoriasis (PS). Therefore, emphasis has lately been laid on the necessity for …

Psoriasis and Cardiovascular Risk--Do Promising New Biomarkers Have Clinical Impact?

S Kaur, K Kingo, M Zilmer - Mediators of Inflammation, 2017 - go.gale.com
Epidemiological studies suggest an increased prevalence of cardiovascular disease (CVD)
in patients with psoriasis (PS). Therefore, emphasis has lately been laid on the necessity for …

[PDF][PDF] Psoriasis and Cardiovascular Risk—Do Promising New Biomarkers Have Clinical Impact?

S Kaur, K Kingo, M Zilmer - 2017 - pdfs.semanticscholar.org
Epidemiological studies suggest an increased prevalence of cardiovascular disease (CVD)
in patients with psoriasis (PS). Therefore, emphasis has lately been laid on the necessity for …

Psoriasis and Cardiovascular Risk—Do Promising New Biomarkers Have Clinical Impact?

S Kaur, K Kingo, M Zilmer - Mediators of Inflammation, 2017 - search.proquest.com
Epidemiological studies suggest an increased prevalence of cardiovascular disease (CVD)
in patients with psoriasis (PS). Therefore, emphasis has lately been laid on the necessity for …

Psoriasis and Cardiovascular Risk—Do Promising New Biomarkers Have Clinical Impact?

S Kaur, K Kingo, M Zilmer - Mediators of Inflammation, 2017 - search.ebscohost.com
Epidemiological studies suggest an increased prevalence of cardiovascular disease (CVD)
in patients with psoriasis (PS). Therefore, emphasis has lately been laid on the necessity for …

Psoriasis and Cardiovascular Risk-Do Promising New Biomarkers Have Clinical Impact?

S Kaur, K Kingo, M Zilmer - Mediators of inflammation, 2017 - pubmed.ncbi.nlm.nih.gov
Epidemiological studies suggest an increased prevalence of cardiovascular disease (CVD)
in patients with psoriasis (PS). Therefore, emphasis has lately been laid on the necessity for …

Psoriasis and Cardiovascular Risk-Do Promising New Biomarkers Have Clinical Impact?

S Kaur, K Kingo, M Zilmer - Mediators of Inflammation, 2017 - europepmc.org
Epidemiological studies suggest an increased prevalence of cardiovascular disease (CVD)
in patients with psoriasis (PS). Therefore, emphasis has lately been laid on the necessity for …